2024/08/16 10:36:06 | |
---|---|
Price | |
26.265 EUR | |
Difference | 0.40% (0.11) |
ISIN | US7170811035 |
Symbol | PFE |
Exchange | Euronext Milan MTF Global Equity Market |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 148,269 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 26.23 EUR (766) |
Ask (Ask size) | 26.31 EUR (766) |
Open | 26.995 EUR |
High | 26.995 EUR |
Low | 26.15 EUR |
Close (prev. day) | 26.16 EUR |
VWAP | 26.318193 EUR |
Volume (pcs) | 7,420 |
Trading volume | 195,281.00 |
Number of trades | 28 |
Last size | 38 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings | ||
2024/07/03 | Global Strategy 3Q 2024 | ||
2024/06/21 | Global Equity Ratings |
2024/08/16 10:36:06 | |
---|---|
Price | |
26.265 EUR | |
Difference | 0.40% (0.11) |
ISIN | US7170811035 |
Symbol | PFE |
Exchange | Euronext Milan MTF Global Equity Market |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 148,269 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 26.23 EUR (766) |
Ask (Ask size) | 26.31 EUR (766) |
Open | 26.995 EUR |
High | 26.995 EUR |
Low | 26.15 EUR |
Close (prev. day) | 26.16 EUR |
VWAP | 26.318193 EUR |
Volume (pcs) | 7,420 |
Trading volume | 195,281.00 |
Number of trades | 28 |
Last size | 38 |
6m | 1Y | 3Y | |
Perf (%) | +3.60% | - | - |
Perf (abs.) | +0.91 | - | - |
Beta | 0.09 | 0.19 | 0.38 |
Volatility | 25.05 | - | - |
Ø price 5 days | Ø volume 5 days (pcs.) | 26.229 EUR (2,980) |
Ø price 30 days | Ø volume 30 days (pcs.) | 26.966 EUR (4,457) |
Ø price 100 days | Ø volume 100 days (pcs.) | 26.010 EUR (4,615) |
Ø price 250 days | Ø volume 250 days (pcs.) | - EUR (-) |
YTD High | date | 29.295 EUR (2024/07/30) |
YTD Low | date | 23.550 EUR (2024/04/26) |
52 Weeks High | date | - EUR (-) |
52 Weeks Low | date | - EUR (-) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/08/16 | 11:53 | 26.28 EUR | 0.52 | 166 |
Vienna Stock Exchange | 2024/08/16 | 11:00 | 26.325 EUR | 0.01 | 4 |
Tradegate | 2024/08/16 | 11:56 | 26.28 EUR | 0.64 | 93 |
Stuttgart | 2024/08/16 | 11:30 | 26.285 EUR | 0.03 | 6 |
NYSE | 2024/08/15 | 22:01 | 28.71 USD | 822.83 | 148,895 |
Munich | 2024/08/16 | 08:00 | 26.085 EUR | 0.00 | 1 |
London Stock Exchange | 2024/08/15 | 17:35 | 28.65 USD | 0.00 | 16 |
Hanover | 2024/08/16 | 08:01 | 26.155 EUR | 0.00 | 1 |
Hamburg | 2024/08/16 | 11:17 | 26.29 EUR | 0.00 | 3 |
Frankfurt | 2024/08/16 | 11:46 | 26.285 EUR | 0.09 | 6 |
Euronext Milan MTF Trading After Hours | 2024/07/25 | 18:24 | 27.00 EUR | 0.00 | 2 |
Euronext Milan MTF Global Equity Market | 2024/08/16 | 10:36 | 26.265 EUR | 0.20 | 28 |
Duesseldorf | 2024/08/16 | 09:30 | 26.215 EUR | 0.00 | 2 |
Berlin | 2024/08/16 | 08:08 | 26.095 EUR | 0.00 | 1 |
PFIZER INC. |
- - |
66 Hudson Boulevard East - 10001-2192 New York |
Telefon: +1-212-733-2323 |
Fax: + |
E-mail: - |
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY. |
Dan Littman | Member of Board of Directors |
Helen Hobbs | Member of Board of Directors |
Scott Gottlieb | Member of Board of Directors |
Susan Desmond-Hellmann | Member of Board of Directors |
Susan Hockfield | Member of Board of Directors |
Cyrus Taraporevala | Member of Board of Directors |
James Quincey | Member of Board of Directors |
James Smith | Member of Board of Directors |
Joseph Echevarria | Member of Board of Directors |
Ronald Blaylock | Member of Board of Directors |
Shantanu Narayen | Member of Board of Directors |
Suzanne Johnson | Member of Board of Directors |
Albert Bourla | Chairman of Managing Board |
Aamir Malik | Member of Executive Committee |
Alexandre de Germay | Member of Executive Committee |
Chris Boshoff | Member of Executive Committee |
Dave Denton | Member of Executive Committee |
Douglas M. Lankler | Member of Executive Committee |
Lidia Fonseca | Member of Executive Committee |
Mikael Dolsten | Member of Executive Committee |
Mike McDermott | Member of Executive Committee |
Payal Sahni Becher | Member of Executive Committee |
Rady A. Johnson | Member of Executive Committee |
Sally Susman | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer